The Ebola crisis has brutally exposed the "age-old failures" of the humanitarian aid system with the World Health Organisation and governments repeating the mistakes of past public health emergencies, the medical charity Médecins Sans Frontières (MSF) has said.
A collaboration between the Humanitarian OpenStreetMap Team (HOT), Médecins Sans Frontières (MSF) and the British and American Red Cross, Missing Maps aims to use remote mapping to develop free, open-source maps for every settlement on Earth – particularly those areas prone to disaster and diseases such as Ebola.
Around 2,200 of the migrants were first picked up by rescuers from the Migrant Offshore Aid Station (MOAS), an independent Maltese operation supported by the medical charity Médecins Sans Frontières (MSF).
In Liberia, medical charity Médecins Sans Frontières (MSF) said it was withdrawing from northern Lofa county, a former Ebola hotspot, after no new patients were recorded at its treatment centre in Foya since 30 October, allowing the centre's staff to be redeployed.
A French NGO, Médecins Sans Frontières (MSF), stopped emergency fund-raising, saying it did not need more.
UPDATE 1815 BST: FIRST PERSON ACCOUNT FROM SAADA UNDER THE BOMBSA Médecins Sans Frontières (MSF) team spent last night in the city of Saada under intense bombing from the coalition led by Saudi Arabia.
This article has been amended to make clear that the MSF report marks the first anniversary of the date of the official outbreak of Ebola in west Africa.
The report says 2014 was a very demanding year in which MSF was stretched way beyond its limits.
Related: Media and communications: the first line of defence against Ebola That all changed last August, by which time the virus had killed more than 1,000 people, and MSF doctors in Liberia were being forced to turn away dying patients as treatment centres were full.
MSF and its partners in the trials, who include academics, pharmaceutical companies and the World Health Organisation, have agreed to run two trials in Guinea, one of which will investigate the use of blood products from people who have survived Ebola.
MSF said it was crucial that if a drug worked, the patients in the treatment centre could continue to get it.
